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A B S T R A C T
Lysine 27 to methionine (K27 M) mutation of the histone variant H3.3 drives the formation of an aggressive
glioblastoma multiforme tumor in infants. Here we analyzed how the methionine substitution alters the stabil-
ity of H3.3 nucleosomes in vitro and modifies its kinetic properties in live cells. We also determined whether
the presence of mutant nucleosomes perturbed the mobility of the PRC2 subunit Ezh2 (enhancer-of-zeste ho-
molog 2). We found that K27 M nucleosomes maintained the wild-type molecular architecture both at the
level of bulk histones and single nucleosomes and followed similar diffusion kinetics to wild-type histones
in live cells. Nevertheless, we observed a remarkable differential recovery of Ezh2 in response to transcrip-
tional stress that was accompanied by a faster diffusion rate of the mobile fraction of Ezh2 and a significantly
increased immobile fraction, suggesting tighter chromatin binding of Ezh2 upon transcription inhibition. The
differential recovery of Ezh2 was dependent on transcription, however, it was independent from K27 M mu-
tation status. These biophysical characteristics shed more light on the mechanism of histone H3.3 K27M in
glioma genesis in relation to the kinetic properties of Ezh2.
© 2017.
1. Introduction
Lysine 27 to methionine (K27 M) substitution of the H3F3A gene,
encoding the replication-independent histone variant H3.3, was the
first somatic histone gene mutation implicated in tumor development
[1–3]. H3.3 K27M nucleosomes drive the formation of the highly ag-
gressive and difficult-to-treat juvenile brain tumor, pediatric glioblas-
toma multiforme (GBM), which becomes manifested through mole-
cular mechanisms that are only partially understood [1,4,5]. The ly-
sine to methionine substitution was suggested to reduce the catalytic
activity of Ezh2, the methyl-transferase subunit of the PRC2 K27
methylase complex, resulting in a global decrease of H3K27 trimethy-
lation and ectopic chromatin binding of Ezh2 [6–8]. Besides cat-
alyzing H3K27 methylation and polycomb-mediated gene repression,
Ezh2 also acts as a transcriptional activator by modulating the activ-
ity of transcription factors and non-histone substrates [9,10]. EZH2
mutations have not been observed in pediatric GBM [11]; therefore,
it is not clear whether K27 M nucleosomes inactivate Ezh2, mim-
icking the effect of EZH2 loss-of-function mutations found in
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many cancers other than GBM, or perturb the non-canonical (i.e.,
PRC2-independent) function of Ezh2 associated with transcriptional
activation.
In this study, we aimed to determine whether the H3.3 K27M mu-
tation changes the architecture of nucleosomes and interferes with
the mobility and transcriptional relationships of histone H3.3 and of
Ezh2 within live human cells. We applied various methodologies (sin-
gle-molecule Förster resonance energy transfer - FRET, fluorescence
correlation spectroscopy - FCS, fluorescence recovery after photo-
bleaching - FRAP) to answer these questions.
2. Material and methods
2.1. In vitro nucleosome reconstitution
Mononucleosomes were reconstituted using a salt-dialysis proto-
col [12]. Widom-601 DNA [13] and recombinant Xenopus laevis his-
tones were reconstituted into normal or H3K27 M nucleosomes. The
Widom-601 was labeled at −53 nt (Alexa 594) and +41 nt (Alexa 488)
with respect to the dyad axis. Octamers were mixed in 2 M NaCl-TE
buffer and reconstituted by slow dialysis down to 5 mM NaCl-TE us-
ing Slyde-A-Lyzer Mini dialysis tubes (7K MWCO, Thermo-Scien-
tific) and a dialysis bag (Spectrapor 7K).
http://dx.doi.org/10.1016/j.bbrc.2017.06.133
0006-291/© 2017.
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2.2. Bulk and single-pair FRET experiments
For bulk FRET, a Typhoon 9400 fluorescence scanner (GE Health-
care) was used to determine proximity ratios at the level of nucleo-
some populations. Samples at different NaCl concentrations were in-
cubated in 384-well microplates prior to measurement and measured
in triplicates. The final concentration of labeled nucleosomes was
∼1 nM. All images were acquired with 100 μm pixel resolution such
that the image plane was set 3 mm above the scanner surface. Fluores-
cence emission was detected in three spectral channels: donor chan-
nel (excitation at 488 nm, detection at 500–540 nm); acceptor channel
(excitation at 532 nm, detection at 595–625 nm); energy transfer chan-
nel (excitation at 488 nm, detection at 595–625 nm). Detection volt-
ages of the two photomultiplier tubes (PMT) were set between 600
and 700 V. Using the Image Quant software, the proximity ratios were
calculated based on intensity values of each acquired image and plot-
ted against the increasing NaCl concentration. Correction factors were
determined prior to each measurement. In the spFRET setup, the fi-
nal concentration of labeled nucleosomes was ∼50 pM supplemented
with 250 pM of unlabeled nucleosomes. Experiments were carried out
using a specific confocal system [14] illuminated continuously with a
491 nm laser (Cobold) for excitation. Prior to burst analysis the nu-
cleosomes were incubated with or without an Ezh2 complex (Active
Motif) for 60 min at room temperature. The confocal volume was cal-
ibrated with Alexa 488 fluorophore using an ALV5000/E autocor-
relator (ALV-Laser GmbH. Langen, Germany), and autocorrelation
curves were fitted. After donor excitation fluorescence emission was
separated into two detection windows for donor (520–560 nm) and ac-
ceptor (>600 nm). Emitted photons were collected by two avalanche
photodiodes (APD, Perkin Elmer Optoelectronics). Single molecule
bursts were collected by TimeHarp2000 (PicoQuant), and analyzed by
the software Frettchen [14,15], where one burst was defined as a group
of at least 50 photons with a mutual separation of less than 120 μs?
Proximity ratio (P) histograms were plotted based on the selected sin-
gle events and analyzed by IGOR Pro software (WaveMetrics). P is
related to the energy transfer efficiency depending on the distance be-
tween the fluorophores.
where NA and ND represent the number of detected photons in the re-
spective channels. In both spFRET and bulk systems the correction
factors (background and cross talk) needed for P determination were
determined in independent measurements.
2.3. Cell culture and transfection
HeLa cells were grown in RPMI-1640 (Sigma, R5886) supple-
mented with 10% (v/v) fetal calf serum, 2 mM glutamine, penicillin
and streptomycin, in 5% CO2 humidified chamber. H3.3 K27M
point-mutation was introduced into a pEGFP-N1-H3.3 and pm-
Cherry-N1-H3.3 plasmid [16], using the quick change mutagenesis
technique. EZH2 was PCR amplified from the NM_004456 (EZH2)
Human cDNA ORF Clone (OriGene), and the amplicon was cloned
into a pEGFP-N1 and pmCherry-N1 plasmid, respectively. Transient
and stable transfections were carried out by Lipofectamine 2000 (In-
vitrogen) or polyethylenimine PEI-B [17]. Where indicated, cells
were pre-treated for 60 min with actinomycin D (5 μg/ml), cyclohex-
imide (20 μg/ml) and flavopiridol (100 nM).
2.4. Confocal laser scanning microscopic (CLSM) analysis
HeLa cells were fixed with 1% formaldehyde prior to each mea-
surement. Images were acquired using an Olympus FluoView 1000
confocal microscope supplied with a 60 × oil immersion objective
(NA 1.35). Excitation and emission filters were as follows: EGFP,
488 nm excitation, 500–540 nm detection; mCherry, 543 nm excita-
tion, 600–680 nm detection. Ten optical slices (0.7–1.1 μm) were col-
lected from each nucleus, applying the Kalman filter mode to reduce
noise and alternative excitation to exclude crosstalk. Colocalization
between Ezh2-mCherry and H3.3-EGFP or H3.3 K27M-EGFP was
computed by the JACoP plugin in ImageJ [18].
2.5. Fluorescence recovery after photobleaching
FRAP measurements were performed in HeLa cells using an
Olympus FluoView 1000 confocal microscope, based on an inverted
IX-81 stand with an UPlanAPO 60 × (NA 1.2) water immersion ob-
jective. EGFP was excited by the 488-nm Argon-ion laser line and
fluorescence was detected through a 500–550 nm band-pass filter. In
the histone FRAP measurements, EGFP-H3.3 or EGFP-H3.3 K27M
HeLa cells were randomly selected and five pre-bleach images were
taken (256 × 256-pixel area, 10 × zoom, ∼9 μW laser power at the ob-
jective), which was followed by a 500 ms bleach period of 100% laser
power (900 μW). Rectangular areas were selected as bleach ROIs. In
the first 90 min, images were acquired every 10 min and then every
30 min, up to 420 min (7 h). Transcription was inhibited by flavopiri-
dol (flav, 100 nM) or actinomycin D (act D, 5 μg/ml), while trans-
lation was repressed by cycloheximide (CHX, 20 μg/ml). The drugs
were added 60 min before the onset of measurements. Actinomycin
D caused a significant (∼90%) loss of the initial (pre-bleach) EGFP
signal, preventing the long-term tracking of fluorescence recoveries.
At these time-points, FRAP recoveries were not calculated. FRAP ex-
periments on Ezh2-EGFP was performed under similar conditions to
those on histones, except that fluorescence signal was tracked for 10 s.
2.6. Fluorescence correlation spectroscopy
FCS measurements on histones. HeLa cells were transfected by
H3.3-EGFP or H3.3 K27M-EGFP and analyzed by a special fluores-
cence fluctuation microscope [19]. Fluorescence excitation of EGFP
was elicited by a Cobold laser (at 491 nm, 5–15 μW outgoing power,
1 μW excitation power at the objective). EGFP emission was detected
through a 515–545 nm band-pass filter using an avalanche photodiode
(APD). Measurements were performed at 37 °C.
FCS measurements on Ezh2. An Olympus FluoView 1000 confo-
cal microscope was used and autocorrelation curves were calculated
by an ALV-5000E correlation card at three randomly selected points
of each nuclei, with 10 × 8 s runs. Measurements were performed at
room temperature (22 °C).
FCS data processing and autocorrelation curve fitting. The Quick-
Fit 3.0 software was used (Krieger, Jan; http://www.dkfz.de/
Macromol/quickfit/) applying a 3D normal diffusion model for
two-component fitting:
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where τ is the lag time, τtr is the triplet correlation time, τ1 and τ2 are
the diffusion times of the fast and slow species, ρ1 and ρ2 = 1 − ρ1
are the fractional amplitudes of the two components, N is the aver-
age number of molecules in the detection volume, and γ is the aspect
ratio of the ellipsoidal detection volume. Autocorrelation curves dis-
torted by aggregates floating through the focus were excluded from
the analysis.
3. Results
3.1. Characterization of H3 K27 M nucleosomes by FRET
To determine how lysine 27 to methionine substitution affects the
stability of H3 K27 M nucleosomes, we introduced the K27 M point
mutation into a recombinant histone H3 and expressed all the core hi-
stones (H2A, H2B, H3, H3 K27 M, and H4) in E. coli (Fig. 1). Pu-
rified histone proteins were assembled into wild-type and K27 M oc-
tamers, then combined and reconstituted into nucleosomes with a Se-
lex 601 (Widom 601) positioning DNA [17]. Fluorescent tags were
incorporated into the Widom 601 sequence creating suitable donor/
acceptor fluorophore pairs for subsequent FRET analyses. We mea-
sured the equilibrium stability of wild-type and K27 M nucleosomes
by microplate-scanning (bulk) FRET [25], allowing us to obtain struc-
tural and kinetic information about the assembly of nucleosomes in
the time range of minutes. Energy transfer proximity ratios (P) were
computed at gradually increasing salt concentrations that elicited nu-
cleosome disassembly in a controlled way (Fig. 1/b). By comparing
the dissociation kinetics of wild-type and mutant samples we found a
small reduction in the salt-dependent stability of K27 M nucleosomes;
however, the difference was not statistically significant. Supplement-
ing the reconstituted nucleosomes with a recombinant Ezh2-complex
(Ezh2, EED, Suz12) resulted in no detectable change in nucleosome
stability (Fig. S1). Since the properties of individual nucleosomes are
averaged in bulk FRET measurements, subtle differences might re-
main undetected over the whole molecular assembly process. There-
fore, we repeated the salt dissociation measurements using single-pair
FRET (spFRET), allowing us to track potential sub-populations. In
the spFRET setup, 50 pM fluorescent nucleosomes were mixed with
250 pM of unlabeled nucleosomes, and proximity ratio histograms
were recorded for a range of salt concentrations (Fig. 1/c and Fig. S2).
At the level of individual nucleosomes, the disassembly process did
not reveal a significant difference or structural heterogeneity between
wild-type and K27 M nucleosomes. We conclude that H3.3 K27M nu-
cleosomes maintain a canonical molecular architecture.
3.2. Functional analysis of H3.3 K27M nucleosomes in live cells
H3.3 K27M mutation has a dominant negative character in hu-
mans [6], which makes functional studies possible in the genetic con-
text of endogenous (wild-type) H3.3 expression. We tagged Ezh2
with mCherry and co-expressed the fusion protein with H3.3-EGFP
or H3.3 K27M-EGFP (Fig. 2/a). We used confocal laser scanning mi-
croscopy (CLSM) to analyze the distribution of Ezh2-mCherry in re-
lation to H3.3-EGFP and H3.3 K27M-EGFP (Fig. 2). Based on the
Manders' colocalization coefficients [18,21], about half of the Ezh2
pool overlapped with histone H3.3 or H3.3 K27M, while the other half
occupied distinct nuclear compartments (Fig. 2/b and Supplementary
Fig. S3). The pattern of colocalization and genomic distribution of
Ezh2 was not changed significantly by the K27 M mutation, or upon
transcriptional inhibition elicited by actinomycin D and flavopiridol
treatments.
Next, we performed kinetic measurements to assess the diffu-
sional properties of Ezh2, H3.3 and H3 K27 M histones at various
spatial and temporal resolutions (Figs. 3–4). By FRAP analysis we
studied HeLa cells stably expressing histone H3.3-EGFP or H3.3
K27M-EGFP (histone FRAP), and Ezh2-EGFP in the presence of
wild-type or K27 M mutant histones (Ezh2 FRAP). The transcrip-
tion-dependence of H3.3-EGFP/K27 M and Ezh2-EGFP mobility was
assessed by comparing control and transcriptionally stressed HeLa
cells. The time-range of measurements was two-fold: at the scale
of hours (up to 8 h) for the core histone molecules (histone FRAP,
Fig. 3/a), and at the scale of seconds (Ezh2 FRAP, Fig. 3/b) for the
fast Ezh2 molecules, recovering as fast as most transcription factors
[22,23]. In the histone FRAP experiments, nascent protein synthesis
was inhibited by cycloheximide (CHX) to avoid the perturbing ef-
fect of newly translated histone-EGFP molecules. We found that the
recovery of H3.3/K27M-EGFP fluorescence did not reach the initial
pre-bleach value such that most histone molecules remained in the
slowly exchanging fraction (Fig. 3/a). Actinomycin D increased the
immobile (unrecovered) fraction of H3.3 and H3.3 K27M (from 55%
to 85%), suggesting strong and direct chromatin binding requiring
the process of transcription. Interestingly, the pTEFb (transcriptional
elongation factor) inhibitor flavopiridol [24] did not change signifi-
cantly the repopulation rate of H3.3/K27 M nucleosomes, implying
that nascent RNA elongation was dispensable for the chromatin bind-
ing of H3.3. The same general pattern was observed after cyclohex-
imide treatment, i.e., most recovery events involved preexisting his-
tones. As opposed to the more static histone molecules, Ezh2-EGFP
fully recovered in less than 10 s under normal growth conditions, lack-
ing an apparent immobile fraction (Fig. 3/b). Flavopiridol and actino-
mycin D treatments induced the formation of a stable immobile frac-
tion of Ezh2 (15% and 35%, respectively). This suggests that Ezh2 has
a non-canonical cellular pool that is associated with active transcrip-
tion, but it is independent from H3.3 K27M mutation.
To scale up the temporal and spatial resolution of our measure-
ments and gain kinetic information in the sub-second time range and
sub-micrometer distance range, we applied FCS (Fig. 4) allowing us
to track several diffusion parameters. From the rate and frequency
of fluorescence intensity fluctuations we computed the time-depen-
dent autocorrelation function (G(τ)), fitted with a 3D normal diffusion
model, supposing two autonomous diffusing components (Fig. 4/a and
Supplementary Fig. S5). The average ratio of fast components, corre-
sponding to the fraction of molecules freely diffusing across the nu-
cleoplasm, was 61% (SD = 19) for H3.3-EGFP and 56% (SD = 20)
for H3.3 K27M-EGFP, respectively (Fig. 4/b, left panel). The pro-
portion of mobile pool increased by 10% after actinomycin D treat-
ment (p < 0.05) in the case of H3.3 K27M. The average diffusion co-
efficient (D) was the same for wild-type and K27 M mutant histones
(31 ± 19 μm2/s and 29 ± 16 μm2/s) and it was not affected by tran-
scription inhibition (act D) or impaired protein synthesis (CHX) (Fig.
4/b, middle panel). The average fraction of the fast component was
∼60% for Ezh2-EGFP (Fig. 4/c, left panel), which slightly increased
in the presence of H3.3 K27M-mCherry (p < 0.05) and after tran
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Fig. 1. FRET analysis of reconstituted nucleosomes. (a) Schematic workflow of the experiment. nc: reconstituted nucleosome, M: 100 bp ladder. (b) Salt-dependent destabilization of
wild-type (black) and H3K27 M (red) nucleosomes measured by bulk FRET. The decrease of proximity ratios (P) reflects nucleosome dissociation. Dots represent the mean of five
independent experiments (±SEM). (c) Distribution of P on single nucleosomes measured by single-pair FRET. Wild-type (black) and H3K27 M (red) nucleosomes, and free DNA
(blue) were measured in parallel at various salt concentrations. One representative measurement performed at 5 mM NaCl is shown. Intact nucleosomes appear at a P of ∼0.4. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. Microscopic analysis of H3.3 K27M nucleosomes in relation to Ezh2. CLSM was performed in HeLa cells expressing H3.3-EGFP or H3.3 K27M-EGFP (green) and
Ezh2-mCherry (red). Representative optical stacks are shown. Scale bar: 5 μm. (a) Nuclear distribution of H3.3-EGFP/H3.3 K27M-EGFP and Ezh2-mCherry under normal growth
conditions (ctrl) and after transcriptional inhibition induced by actinomycin D (act D, 5 μg/ml, 60 min) or flavopiridol (flav, 100 nM, 60 min). (b) Quantification of colocalization
between H3.3-EGFP/H3.3 K27M-EGFP and Ezh2-mCherry based on the Manders correlation coefficient. For statistical comparison, two-tailed t-tests were performed at a level of
significance of 0.05 (*p < 0.05). The number of cases (N) was ≥60. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
scription inhibition by flavopiridol (p < 0.05). The latter pool of
Ezh2-EGFP also had a higher mobility (Fig. 4/c, middle panel), re-
flected by the increased diffusion coefficients of flavopiridol inhibited
cells (p < 0.05). This suggests that the nuclear mobility of Ezh2 is sig-
nificantly restrained by transcription elongation, independently from
the presence of H3.3 K27M mutation.
When the diffusion coefficients of the fast populations were con-
verted into apparent molecular masses (based on the Stokes-Einstein
equation for spherical objects [25]), there was no significant differ-
ence between the real and apparent masses of H3/H3 K27M-EGFP
molecules (55.9 kDa/49.26 kDa vs. 42.26 kDa) (Fig. 4/b, right panel),
however, Ezh2-EGFP gave ∼10-fold larger molecular mass than the
real molecular mass of the fusion protein (1.221 kDa/1.900 kDa vs.
102.36 kDa, Fig. 4/c, right panel). This difference reflects that Ezh2 is
part of large protein complexes. The apparent molecular masses were
not affected by the presence of K27 M mutation.
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Fig. 3. Measuring the kinetics of H3.3 K27M nucleosomes and Ezh2 in live cells:
a FRAP approach. (a) FRAP curves of histone H3.3-EGFP and H3.3 K27M-EGFP,
expressed in live cells under normal growth conditions and after transcriptional and
translational inhibition. Transcription and translation were inhibited by flavopiridol
(flav, 100 nM)/actinomycin D (act D, 5 μg/ml) and cycloheximide (CHX, 20 μg/ml),
respectively. The drugs were added 1 h before the measurements. (b) Recovery curves
of Ezh2-EGFP in the presence of wild-type (H3.3-mCherry) or mutant (H3.3
K27M-mCherry) nucleosomes.
4. Discussion
Evidence is emerging that epigenetic mutations disrupting
post-translational histone modifications play an etiological role in the
development of cancer. Earlier studies showed that selective changes
of single amino acids or histone tail clipping (in molecular dynamics
simulations) significantly altered the stability and dynamic properties
of nucleosome core particles [26–28]; however, similar structural re-
arrangements have not been investigated in the case of H3.3 K27M.
Another crucial point is related to Ezh2 that stimulates the expression
of a number of target genes independently from its H3K27 methylase
activity [11]. The switch between the repressive and stimulatory roles
of the double-facet protein Ezh2 is not understood at the molecular
level.
Herein we found that K27 M nucleosomes maintained their
wild-type molecular architecture and stability, suggesting that single
amino acid substitution of the N-terminal H3 tail domain did not cause
detectable rearrangements in the structure of NPCs In live human
cells, K27 M nucleosomes followed similar diffusion kinetics to their
wild-type counterparts and fully recapitulated the slow kinetics and
tight chromosome binding of canonical (replication-dependent) H3
molecules [29]. Nevertheless, by FRAP and FCS we found a remark-
able differential recovery of Ezh2 in response to transcriptional stress
that was accompanied by a significantly increased immobile fraction
and faster diffusion rate of the mobile fraction of Ezh2. The differen-
tial recovery of Ezh2 was dependent on transcription, however, it was
independent from K27 M mutation status. The lack of a significant ad-
verse effects of K27 M is consistent with the recent demonstration of
the ability of other post-translational histone modifications surround-
ing the lysine 27 residue to detoxify the K27 M mutation in vivo [30].
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Fig. 4. Measuring the diffusion of H3.3 K27M and Ezh2 by FCS. (a) Representative autocorrelation curves. Histone H3.3-EGFP (blue), histone H3.3 K27M-EGFP (red), Ezh2-EGFP
(orange), and EGFP (green). (b) Left Panel: Average fraction of the fast diffusion component of H3.3/H3.3 K27M-EGFP under normal metabolic conditions and upon transcription
or translation inhibition (actinomycin D (act D, 5 μg/ml), and cycloheximide (CHX, 20 μg/ml)). Significant difference is indicated (*p < 0.05, two-tailed t-test). The number of cases
(N) analyzed was ≥28. Error bar: SEM. Median values are indicated in the boxplots. Middle Panel: Distribution of diffusion coefficients of H3.3/H3.3 K27M-EGFP after two-com-
ponent fitting. Right Panel: Distribution of apparent molecular masses of H3.3/H3.3 K27M-EGFP, and EGFP. (c) Left Panel: The average fraction of fast diffusion components of
Ezh2-EGFP in the presence of wild type (H3.3-mCherry) or mutant (H3.3 K27M-mCherry) histones under normal metabolic conditions and upon transcription inhibition (actino-
mycin D (act D, 5 μg/ml), and flavopiridol (flav, 100 nM)). Statistical significance is indicated (*p < 0.05). Middle Panel: Distribution of diffusion coefficients of Ezh2-EGFP in the
presence of wild-type (H3.3-mCherry) or mutant (H3.3 K27M-mCherry) histones. Statistical significance is indicated (*p < 0.05; **p < 0.001, Mann-Whitney rank sum test). Right
Panel: Distribution of apparent molecular masses of Ezh2-EGFP in the presence of wild-type (H3.3-mCherry) or mutant (H3.3 K27M-mCherry) histones, or EGFP. (For interpreta-
tion of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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